Peter is an experienced life-science industry consultant with over thirty-five years’ experience in the pharmaceutical and biotech industry, spanning all areas of the business from sales representative to country-level general manager and CEO and companies ranging from multinationals like Abbott and Glaxo to start-up biotechs. At Glaxo Wellcome in the mid-1990s he led the global introduction of combination HIV therapy while keying industry leadership on global treatment access. Currently Peter serves as a venture partner with Pappas Capital, where he leads the firm’s initiatives in translational medicine and is the Program Manager for Wake Forest Baptist Medical Center’s Technology Development Program. He also serves as an Executive in Residence at Cold Spring Harbor Laboratories and the Center for Biotechnology at Stony Brook University. He is a member of the Oversight Committee for the University of Miami Wallace H. Coulter Center for Translational Research, the Long Island Bioscience Hub External Review Board and the Long Island Biomentor Initiative, a past member of the BIO board and chairman of the North Carolina Biosciences Organization, and a director of Memory Pharmaceuticals from 2004 until its sale to Roche in 2009. Peter has lived and worked in the US, Greece and the Middle East, Puerto Rico, New Zealand, and London, and currently lives with his family in New York. He has a BA and an MBA from Indiana University.
1:45 PM - 2:45 PM
Wednesday, June 5
According to research from the US Health and Human Services, US tax payers pay 1.8 times the…